RU2006101689A - Улучшенный способ получения альфа-полиморфного бромгидрата элетриптана - Google Patents
Улучшенный способ получения альфа-полиморфного бромгидрата элетриптана Download PDFInfo
- Publication number
- RU2006101689A RU2006101689A RU2006101689/04A RU2006101689A RU2006101689A RU 2006101689 A RU2006101689 A RU 2006101689A RU 2006101689/04 A RU2006101689/04 A RU 2006101689/04A RU 2006101689 A RU2006101689 A RU 2006101689A RU 2006101689 A RU2006101689 A RU 2006101689A
- Authority
- RU
- Russia
- Prior art keywords
- methylpyrrolidin
- ylmethyl
- indole
- polymorphic
- eletriptan
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 15
- 238000000034 method Methods 0.000 claims 10
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical compound CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 claims 7
- 229960002472 eletriptan Drugs 0.000 claims 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- GVLGAFRNYJVHBC-UHFFFAOYSA-N hydrate;hydrobromide Chemical compound O.Br GVLGAFRNYJVHBC-UHFFFAOYSA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims 3
- UJTPZISIAWDGFF-UHFFFAOYSA-N ethenylsulfonylbenzene Chemical group C=CS(=O)(=O)C1=CC=CC=C1 UJTPZISIAWDGFF-UHFFFAOYSA-N 0.000 claims 3
- PIIFSFIOOCHDIK-CQSZACIVSA-N 1-[5-bromo-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]indol-1-yl]ethanone Chemical compound CN1CCC[C@@H]1CC1=CN(C(C)=O)C2=CC=C(Br)C=C12 PIIFSFIOOCHDIK-CQSZACIVSA-N 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 238000004821 distillation Methods 0.000 claims 2
- 238000010992 reflux Methods 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- MDVODIFOKYRNHD-OAQYLSRUSA-N 1-[5-[2-(benzenesulfonyl)ethenyl]-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]indol-1-yl]ethanone Chemical compound CN1CCC[C@@H]1CC(C1=C2)=CN(C(C)=O)C1=CC=C2C=CS(=O)(=O)C1=CC=CC=C1 MDVODIFOKYRNHD-OAQYLSRUSA-N 0.000 claims 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 1
- MJICWWOZPCLNBP-LJQANCHMSA-N 5-[2-(benzenesulfonyl)ethenyl]-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]-1h-indole Chemical compound CN1CCC[C@@H]1CC(C1=C2)=CNC1=CC=C2C=CS(=O)(=O)C1=CC=CC=C1 MJICWWOZPCLNBP-LJQANCHMSA-N 0.000 claims 1
- JCXOJXALBTZEFE-GFCCVEGCSA-N 5-bromo-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]-1h-indole Chemical compound CN1CCC[C@@H]1CC1=CNC2=CC=C(Br)C=C12 JCXOJXALBTZEFE-GFCCVEGCSA-N 0.000 claims 1
- YJZFFVYWVXINKV-OAQYLSRUSA-N C(C)(=O)N1C=C(C2=CC(=CC=C12)C#CS(=O)(=O)C1=CC=CC=C1)C[C@@H]1N(CCC1)C Chemical compound C(C)(=O)N1C=C(C2=CC(=CC=C12)C#CS(=O)(=O)C1=CC=CC=C1)C[C@@H]1N(CCC1)C YJZFFVYWVXINKV-OAQYLSRUSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- XMLJCSFKQSJZLS-UHFFFAOYSA-L [K+].[K+].OC.[O-]C([O-])=O Chemical compound [K+].[K+].OC.[O-]C([O-])=O XMLJCSFKQSJZLS-UHFFFAOYSA-L 0.000 claims 1
- 238000004440 column chromatography Methods 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229940098779 methanesulfonic acid Drugs 0.000 claims 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Claims (11)
1. Способ получения α-полиморфного бромгидрата элетриптана, включающий стадии (а) обработки раствора элетриптана в 2-бутаноне бромистоводородной кислотой и (b) отгонки азеотропной смеси 2-бутанона/воды до завершения образования безводного α-полиморфного бромгидрата элетриптана.
2. Способ по п.1, где содержание воды в реакционной смеси уменьшено до менее чем 0,5% мас./мас. на стадии (b).
3. Способ по п.1 или 2, включающий дополнительную стадию суспендирования продукта стадии (b) в орошающем толуоле и удаления части толуола перегонкой.
4. Способ по п.3, где, по меньшей мере, 12% толуола удаляют.
5. Способ по любому из предшествующих пунктов, где исходное вещество элетриптана получают обработкой раствора (R)-5-(2-фенилсульфонилэтенил)-3-(N-метилпирролидин-2-илметил)-1Н-индола в ацетоне палладием на угле и метансульфоновой кислотой в атмосфере водорода.
6. Способ по п.5, где (R)-5-(2-фенилсульфонилэтенил)-3-(N-метилпирролидин-2-илметил)-1Н-индол получают обработкой раствора (R)-1-ацетил-5-(2-фенилсульфонилэтенил)-3-(N-метилпирролидин-2-илметил)-1Н-индола в метаноле карбонатом калия.
7. Способ по п.6, где (R)-5-(2-фенилсульфонилэтенил)-3-(N-метилпирролидин-2-илметил)-1Н-индол очищают колоночной хроматографией.
8. Способ по п.6 или 7, где (R)-1-ацетил-5-(2-фенилсульфонилэтенил)-3-(N-метилпирролидин-2-илметил)-1Н-индол получают обработкой раствора (R)-1-ацетил-5-бром-3-(N-метилпирролидин-2-илметил)-1Н-индола в ацетонитриле триэтиламином, три-о-толилфосфином, ацетатом палладия и фенилвинилсульфоном.
9. Способ по п.8, где (R)-1-ацетил-5-бром-3-(N-метилпирролидин-2-илметил)-1Н-индол получают обработкой раствора (R)-5-бром-3-(N-метилпирролидин-2-илметил)-1Н-индола в ацетонитриле ангидридом уксусной кислоты и триэтиламином.
10. Способ получения кристаллической, α-полиморфной формы бромгидрата элетриптана из любой другой полиморфной и/или сольватированной/гидратированной формы бромгидрата элетриптана или из смеси различных полиморфных и/или сольватированных/гидратированных форм, включая смесь, содержащую α-полимерную форму как таковую, включающий (а) кристаллизацию раствора исходного вещества бромгидрата элетриптана в смеси 2-бутанона и воды и (b) отгонку азеотропной смеси 2-бутанона/воды до завершения образования безводного α-полиморфного бромгидрата элетриптана.
11. Способ по п.10, включающий дополнительную стадию суспендирования продукта стадии (b) в орошающем толуоле и удаления части толуола перегонкой.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0317229.3 | 2003-07-23 | ||
| GBGB0317229.3A GB0317229D0 (en) | 2003-07-23 | 2003-07-23 | Improved process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2006101689A true RU2006101689A (ru) | 2006-06-27 |
| RU2320655C2 RU2320655C2 (ru) | 2008-03-27 |
Family
ID=27772518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006101689/04A RU2320655C2 (ru) | 2003-07-23 | 2004-07-12 | УЛУЧШЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ α-ПОЛИМОРФНОГО БРОМГИДРАТА ЭЛЕТРИПТАНА |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1660485B1 (ru) |
| JP (1) | JP2006528172A (ru) |
| KR (1) | KR100694962B1 (ru) |
| CN (1) | CN100430388C (ru) |
| AR (1) | AR046509A1 (ru) |
| AT (1) | ATE349442T1 (ru) |
| AU (1) | AU2004256994A1 (ru) |
| BR (1) | BRPI0412721A (ru) |
| CA (1) | CA2532111A1 (ru) |
| CO (1) | CO5650232A2 (ru) |
| CY (1) | CY1105980T1 (ru) |
| DE (1) | DE602004003966T2 (ru) |
| DK (1) | DK1660485T3 (ru) |
| ES (1) | ES2274473T3 (ru) |
| GB (1) | GB0317229D0 (ru) |
| IL (1) | IL172765A0 (ru) |
| MX (1) | MXPA06000793A (ru) |
| NO (1) | NO20056238L (ru) |
| NZ (1) | NZ544305A (ru) |
| PL (1) | PL1660485T3 (ru) |
| PT (1) | PT1660485E (ru) |
| RU (1) | RU2320655C2 (ru) |
| TW (1) | TWI291956B (ru) |
| WO (1) | WO2005007649A1 (ru) |
| ZA (1) | ZA200600607B (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1663978E (pt) | 2003-07-23 | 2008-02-15 | Bayer Pharmaceuticals Corp | Omega-carboxiaril difenil ureia substituída por flúor para o tratamento e a prevenção de doenças e estados patológicos |
| JP5214124B2 (ja) | 2006-08-17 | 2013-06-19 | 三星電子株式会社 | 通信システム、通信装置、尤度計算方法、及びプログラム |
| WO2009142771A2 (en) * | 2008-05-22 | 2009-11-26 | Plus Chemicals, S.A. | Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3-[(r)-1- methyl-pyrrolidin-2- ylmethyl]-1h-indole and of eletriptan |
| WO2010116386A2 (en) * | 2009-04-08 | 2010-10-14 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel polymorph of eletriptan hydrobromide and process for the preparation thereof |
| IT1393700B1 (it) * | 2009-04-22 | 2012-05-08 | F S I Fabbrica Italiana Sint | Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo |
| WO2011004391A2 (en) * | 2009-06-25 | 2011-01-13 | Matrix Laboratories Ltd | An improved process for the preparation of eletriptan and its salt thereof |
| US8754239B2 (en) | 2010-01-19 | 2014-06-17 | Sms Pharmaceuticals Limited | Process for preparing eletriptan hydrobromide having α-form |
| WO2012004811A1 (en) * | 2010-07-06 | 2012-01-12 | Ind-Swift Laboratories Limited | Process for the preparation of 5-substsituted indole derivative |
| CN102786514B (zh) * | 2012-07-26 | 2014-01-29 | 武汉人福医药集团股份有限公司 | 依来曲普坦的制备方法 |
| CN104341397A (zh) * | 2013-07-31 | 2015-02-11 | 上海威智医药科技有限公司 | 具晶型的依来曲普坦自由碱及其制法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW288010B (ru) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| FR2701026B1 (fr) * | 1993-02-02 | 1995-03-31 | Adir | Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| WO1996004842A1 (en) * | 1994-08-12 | 1996-02-22 | Thomas Donald D Ii | Miniaturized blood pressure monitor kit |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB0031094D0 (en) * | 2000-12-20 | 2001-01-31 | Pfizer Ltd | New Process |
-
2003
- 2003-07-23 GB GBGB0317229.3A patent/GB0317229D0/en not_active Ceased
-
2004
- 2004-07-12 MX MXPA06000793A patent/MXPA06000793A/es active IP Right Grant
- 2004-07-12 AT AT04743983T patent/ATE349442T1/de not_active IP Right Cessation
- 2004-07-12 RU RU2006101689/04A patent/RU2320655C2/ru not_active IP Right Cessation
- 2004-07-12 PL PL04743983T patent/PL1660485T3/pl unknown
- 2004-07-12 CN CNB2004800204126A patent/CN100430388C/zh not_active Expired - Fee Related
- 2004-07-12 BR BRPI0412721-8A patent/BRPI0412721A/pt not_active IP Right Cessation
- 2004-07-12 WO PCT/IB2004/002322 patent/WO2005007649A1/en not_active Ceased
- 2004-07-12 AU AU2004256994A patent/AU2004256994A1/en not_active Abandoned
- 2004-07-12 ES ES04743983T patent/ES2274473T3/es not_active Expired - Lifetime
- 2004-07-12 JP JP2006520921A patent/JP2006528172A/ja not_active Withdrawn
- 2004-07-12 PT PT04743983T patent/PT1660485E/pt unknown
- 2004-07-12 DE DE602004003966T patent/DE602004003966T2/de not_active Expired - Fee Related
- 2004-07-12 CA CA002532111A patent/CA2532111A1/en not_active Abandoned
- 2004-07-12 EP EP04743983A patent/EP1660485B1/en not_active Expired - Lifetime
- 2004-07-12 KR KR1020067001359A patent/KR100694962B1/ko not_active Expired - Fee Related
- 2004-07-12 NZ NZ544305A patent/NZ544305A/en unknown
- 2004-07-12 DK DK04743983T patent/DK1660485T3/da active
- 2004-07-21 AR ARP040102584A patent/AR046509A1/es unknown
- 2004-07-22 TW TW093121917A patent/TWI291956B/zh active
-
2005
- 2005-12-22 IL IL172765A patent/IL172765A0/en unknown
- 2005-12-27 CO CO05130436A patent/CO5650232A2/es not_active Application Discontinuation
- 2005-12-30 NO NO20056238A patent/NO20056238L/no not_active Application Discontinuation
-
2006
- 2006-01-20 ZA ZA200600607A patent/ZA200600607B/en unknown
-
2007
- 2007-02-01 CY CY20071100145T patent/CY1105980T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1660485A1 (en) | 2006-05-31 |
| DK1660485T3 (da) | 2007-03-19 |
| ES2274473T3 (es) | 2007-05-16 |
| EP1660485B1 (en) | 2006-12-27 |
| CA2532111A1 (en) | 2005-01-27 |
| TWI291956B (en) | 2008-01-01 |
| CY1105980T1 (el) | 2011-04-06 |
| NO20056238L (no) | 2006-04-05 |
| MXPA06000793A (es) | 2006-04-07 |
| PL1660485T3 (pl) | 2007-04-30 |
| AU2004256994A1 (en) | 2005-01-27 |
| AR046509A1 (es) | 2005-12-14 |
| JP2006528172A (ja) | 2006-12-14 |
| TW200510388A (en) | 2005-03-16 |
| WO2005007649A1 (en) | 2005-01-27 |
| RU2320655C2 (ru) | 2008-03-27 |
| DE602004003966D1 (de) | 2007-02-08 |
| GB0317229D0 (en) | 2003-08-27 |
| CO5650232A2 (es) | 2006-06-30 |
| PT1660485E (pt) | 2007-01-31 |
| BRPI0412721A (pt) | 2006-09-26 |
| CN100430388C (zh) | 2008-11-05 |
| ZA200600607B (en) | 2007-05-30 |
| ATE349442T1 (de) | 2007-01-15 |
| KR100694962B1 (ko) | 2007-03-14 |
| IL172765A0 (en) | 2006-04-10 |
| DE602004003966T2 (de) | 2007-05-24 |
| NZ544305A (en) | 2008-09-26 |
| CN1823060A (zh) | 2006-08-23 |
| KR20060030118A (ko) | 2006-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900001509B1 (ko) | (트레오) - 1 - 아릴 - 2 - 아실아미도 - 3 - 플루오로 - 1 - 프로판올 및 그의 제조방법 | |
| RU2006101689A (ru) | Улучшенный способ получения альфа-полиморфного бромгидрата элетриптана | |
| US6448415B1 (en) | Chirality conversion method in lactone sugar compounds | |
| ES2216828T3 (es) | Metodo para producir beta-aminoepoxido y beta-aminoalcohol n-protegido con una funcion carbamato. | |
| RU2003109438A (ru) | Адсорбент для очистки перфторуглерода, способ получения адсорбента, октафторпропан и октафторциклобутан высокой чистоты и их применение | |
| WO2001047949A9 (en) | Aspartame derivative crystals | |
| WO2010104742A2 (en) | Processes for making alkyl halides | |
| EP2357168A1 (en) | Method for producing fluorosulfuric acid ester | |
| EP0057045B1 (fr) | Nouveaux dérivés du 5-hydroxy tétrahydrofuran 2-one | |
| EP1268398B1 (fr) | Nouveau procede de synthese des esters de la n- (s)-1-carboxybutyl]-(s)-alanine et application a la synthese du perindopril | |
| JP2011006379A (ja) | ｛２−アミノ−１，４−ジヒドロ−６−メチル−４−（３−ニトロフェニル）−３，５−ピリジンジカルボン酸３−（１−ジフェニルメチルアゼチジン−３−イル）エステル５−イソプロピルエステル｝（アゼルニジピン）の再結晶方法、アゼルニジピンのイソプロピルアルコール付加体、およびアゼルニジピンの製造方法 | |
| EP1272454A1 (fr) | Procede de synthese des esters de la n-[(s)-1-carboxybutyl]-(s)-alanine et application a la synthese du perindopril | |
| EP0220435B1 (en) | A method for preparing optically active half esters | |
| JP2002234843A5 (ru) | ||
| JP2625490B2 (ja) | ピルビン酸塩の精製方法 | |
| JPH0545572B2 (ru) | ||
| JPH10237009A (ja) | ギ酸メチルからの酢酸の製造方法 | |
| JP4157175B2 (ja) | ２′−ピロリジンプロパン酸誘導体の製造方法 | |
| CN118702614A (zh) | 一种手性氮杂双环酯类化合物的制备方法 | |
| JPS6363536B2 (ru) | ||
| CN107417560A (zh) | 一种合成盐酸替罗酰胺的新方法 | |
| Ammazzalorso et al. | Dynamic kinetic resolution of alpha-bromoesters containing lactamides as chiral auxiliaries | |
| JP4931379B2 (ja) | 光学活性アゼチジン−２−カルボン酸エステル類の製造方法 | |
| CN118159513A (zh) | 制备高纯度(甲基)丙烯酸的方法 | |
| JP3832919B2 (ja) | 光学活性シアンヒドリンの製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090713 |